|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Study Type: | Interventional |
|---|---|
| Study Design: | Allocation: Randomized; Endpoint Classification: Safety Study; Intervention Model: Crossover Assignment; Masking: Open Label; Primary Purpose: Treatment |
| Condition: |
Hypokalemia |
| Interventions: |
Drug: Hydrochlorothiazide Dietary Supplement: Licorice |
Participant Flow
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| No text entered. |
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| No text entered. |
| Description | |
|---|---|
| Licorice First, Then Licorice and HCTZ | Licorice 32 grams a day in the first intervention period, then licorice 32 grams a day together with Hydrochlorothiazide 25 mg once daily in the second intervention period. |
| Licorice and HCTZ First, Then Licorice | Licorice 32 grams a day together with Hydrochlorothiazide 25 mg once daily in the first intervention period, then licorice 32 grams a day in the second intervention period. |
| Licorice First, Then Licorice and HCTZ | Licorice and HCTZ First, Then Licorice | |
|---|---|---|
| STARTED | 5 | 5 |
| COMPLETED | 5 | 5 |
| NOT COMPLETED | 0 | 0 |
| Licorice First, Then Licorice and HCTZ | Licorice and HCTZ First, Then Licorice | |
|---|---|---|
| STARTED | 5 | 5 |
| COMPLETED | 5 | 5 |
| NOT COMPLETED | 0 | 0 |
| Licorice First, Then Licorice and HCTZ | Licorice and HCTZ First, Then Licorice | |
|---|---|---|
| STARTED | 5 | 5 |
| COMPLETED | 5 | 5 |
| NOT COMPLETED | 0 | 0 |
Baseline Characteristics
| Description | |
|---|---|
| Entire Study Population | No text entered. |
| Entire Study Population | |
|---|---|
|
Number of Participants
[units: participants] |
10 |
|
Age
[units: participants] |
|
| <=18 years | 0 |
| Between 18 and 65 years | 10 |
| >=65 years | 0 |
|
Gender
[units: participants] |
|
| Female | 5 |
| Male | 5 |
|
Region of Enrollment
[units: participants] |
|
| Finland | 10 |
More Information
| Principal Investigators are NOT employed by the organization sponsoring the study. |
| There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. |
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| No text entered. |
| Responsible Party: | Professor Markku Savolainen, Oulu University Hospital |
| ClinicalTrials.gov Identifier: | NCT00605202 History of Changes |
| Other Study ID Numbers: | Lakritsi ja hypokalemia |
| Study First Received: | January 17, 2008 |
| Results First Received: | August 13, 2009 |
| Last Updated: | December 10, 2009 |
| Health Authority: | Finland: Finnish Medicines Agency |